Adam Koppel - Director, 10%+ Owner at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Adam Koppel - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by Adam Koppel for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 65,679,781 $2.67 B $40.61 Jun 5, 2024 Indirect
Common Stock 13,743 $558 K $40.61 Jun 5, 2024 Direct
Stock Option (Right to Buy) 13,780 Jun 7, 2023 Direct Common Stock

Transactions reported by Adam Koppel for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership